» Articles » PMID: 35095854

Atypical Ataxia Presentation in Variant Ataxia Telangiectasia: Iranian Case-Series and Review of the Literature

Abstract

Ataxia-telangiectasia (AT) is a rare autosomal recessive neurodegenerative multisystem disorder. A minority of AT patients can present late-onset atypical presentations due to unknown mechanisms. The demographic, clinical, immunological and genetic data were collected by direct interview and examining the Iranian AT patients with late-onset manifestations. We also conducted a systematic literature review for reported atypical AT patients. We identified three Iranian AT patients (3/249, 1.2% of total registry) with later age at ataxia onset and slower neurologic progression despite elevated alpha-fetoprotein levels, history of respiratory infections, and immunological features of the syndrome. Of note, all patients developed autoimmunity in which a decrease of naïve T cells and regulatory T cells were observed. The literature searches also summarized data from 73 variant AT patients with atypical presentation indicating biallelic mild mutations mainly lead to an atypical phenotype with an increased risk of cancer. Variant AT patients present with milder phenotype or atypical form of classical symptoms causing under- or mis- diagnosis. Although missense mutations are more frequent, an atypical presentation can be associated with deleterious mutations due to unknown modifying factors.

Citing Articles

Evaluation of T-cell repertoire by flow cytometric analysis in primary immunodeficiencies with DNA repair defects.

Karaaslan B, Demirkale Z, Turan I, Aydemir S, Meric Z, Taskin Z Scand J Immunol. 2025; 101(2):e70003.

PMID: 39967281 PMC: 11836546. DOI: 10.1111/sji.70003.


Investigating Chromosomal Radiosensitivity in Inborn Errors of Immunity: Insights from DNA Repair Disorders and Beyond.

Beyls E, Duthoo E, Backers L, Claes K, De Bruyne M, Pottie L J Clin Immunol. 2025; 45(1):75.

PMID: 39945898 PMC: 11825639. DOI: 10.1007/s10875-025-01858-2.


ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects.

Salami F, Shad T, Fathi N, Mojtahedi H, Esmaeili M, Shahkarami S J Clin Immunol. 2025; 45(1):67.

PMID: 39853455 PMC: 11762072. DOI: 10.1007/s10875-025-01857-3.


Neurocutaneous Diseases: Diagnosis, Management, and Treatment.

Kioutchoukova I, Foster D, Thakkar R, Ciesla C, Cabassa J, Strouse J J Clin Med. 2024; 13(6).

PMID: 38541874 PMC: 10971194. DOI: 10.3390/jcm13061648.


The clinical spectrum of ataxia telangiectasia in a cohort in Sweden.

Lindahl H, Svensson E, Danielsson A, Puschmann A, Svenningson P, Tesi B Heliyon. 2024; 10(4):e26073.

PMID: 38404774 PMC: 10884802. DOI: 10.1016/j.heliyon.2024.e26073.


References
1.
Roohi J, Crowe J, Loredan D, Anyane-Yeboa K, Mansukhani M, Omesi L . New diagnosis of atypical ataxia-telangiectasia in a 17-year-old boy with T-cell acute lymphoblastic leukemia and a novel ATM mutation. J Hum Genet. 2017; 62(5):581-584. PMC: 5404952. DOI: 10.1038/jhg.2017.6. View

2.
Lee Y, McKinnon P . Responding to DNA double strand breaks in the nervous system. Neuroscience. 2006; 145(4):1365-74. DOI: 10.1016/j.neuroscience.2006.07.026. View

3.
Noordzij J, Wulffraat N, Haraldsson A, Meyts I, Vant Veer L, Hogervorst F . Ataxia-telangiectasia patients presenting with hyper-IgM syndrome. Arch Dis Child. 2009; 94(6):448-9. DOI: 10.1136/adc.2008.149351. View

4.
Necpal J, Zech M, Skorvanek M, Havrankova P, Fecikova A, Winkelmann J . Ataxia Telangiectasia Gene Mutation in Isolated Segmental Dystonia Without Ataxia and Telangiectasia. Mov Disord Clin Pract. 2018; 5(1):89-91. PMC: 6090590. DOI: 10.1002/mdc3.12564. View

5.
Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani S, Momen T . Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis. J Clin Immunol. 2018; 38(7):816-832. DOI: 10.1007/s10875-018-0556-1. View